about
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System disc...
Read More
1.85
-0.09
(-4.64%)
470.8K
XNAS Volume
XNAS 15 Jul, 2025 11:10 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Biomea Fusion Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..